How Ozempic helps manage fatty liver disease Ozempic's active ingredient is semaglutide, a GLP-1 receptor agonist that manages blood sugar by increasing insulin levels, slowing gastric emptying ...

Patients on GLP-1 medications lost about half as much weight as participants did in clinical trials, NYU researchers found.

Mazdutide, used in the treatment of obesity and metabolic diseases, could become the first domestically-developed dual-target ...

A new study found a link between GLP-1s and a higher risk of neovascular age-related macular degeneration, an eye disease ...